Pfizer’s strategy also reflects growing belief among drugmakers obesity eventually may become highly individualized field of medicine.

Detailed data from a midstage study offered further evidence that the obesity drug Pfizer acquired from the biotech Metsera could be dosed monthly.

Pfizer’s strategy also reflects growing belief among drugmakers obesity eventually may become highly individualized field of medicine.